Antiepileptic Drug Therapy: Management Issues and Pregnancy
This chapter draws on material discussed in earlier chapters in an attempt to provide a scientifically based discussion of the management of antiepileptic drug therapy in women with epilepsy who are planning pregnancy, while pregnant and in the postpartum period. The aim of the management is to maintain optimal control of epileptic seizures at all times while also minimising the risks to the foetus from developing structural malformations while still in utero and from encountering neurodevelopmental problems during infancy and childhood. The information regarding the management of antiepileptic drug therapy in pregnant women with epilepsy should also, for the most part, be applicable to the use of these drugs in pregnant women for indications other than epilepsy.
KeywordsStatus Epilepticus Antiepileptic Drug Seizure Control Plasma Drug Concentration Postpartum Depression
- Garfield SS, Armstrong SO (2012) Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies. J Manage Care Med 15:34–41Google Scholar
- Schmidt D (1982) The effect of pregnancy on the natural history of epilepsy: review of the literature. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D (eds) Epilepsy, pregnancy, and the child. Raven, New York, pp 3–14Google Scholar
- Tomson T, Palm R, Kallen K et al (2007b) Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Nat Clin Pract Neurol 310:538–539Google Scholar
- Vajda FJE, Angelis-Stoforidis P, Eadie MJ (1999) Utility of plasma lamotrigine concentration: Concept of the plasma therapeutic range for individual patients. J Neurol 246(Suppl 1):185Google Scholar
- Yerby MS, Kaplan P, Tran T (2004) Risks and management of pregnancy in women with epilepsy. Cleve Clin J Med 71(S25):825–837Google Scholar